Boc-(S)-4-amino-2-carboxymethyl-1,3,4,5-, 99.0%, 250mg

4-Methyl-(5-hydroxymethyl)imidazole hydrochloride, 95.0%, 25g

3-(1-Methanesulfonyl-3,5-dimethyl-1 H -pyrazol-4-yl)-propionic acid ethyl ester, 97%, 1g

((2R,3R,5R)-3-(benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate, 97%, 250mg

4-(Hydroxymethyl)-1-methylpyrrolidin-2-one, 97.0%, 5g

(R)-3-(6-Ethoxy-pyrimidin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

1[2-(Diallylamino-ethyl]-piperazine, 99.0%, 250mg

3,3-Dimethylbutyraldehyde>97.0%(GC)25mL

N-Benzylbenzamide, 99.0%, 500g

Bis(2-iodothiophen-3-yl)methanone, 97%, 5g

1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-BORONIC ACID PINACOL ESTER, 95.0%, 1g

(6-Methylpyridin-3-yl)methanamine, 95.0%, 1g

Réfractomètre pour applications cliniques. Analogique